General
A detailed look at the implications of the Access to Medicine 2016 index
 

A detailed look at the implications of the Access to Medicine 2016 index

Shared by:

 
The pharmaceutical industry is often under scrutiny for not doing enough to ensure that people in low and middle-income countries have access to its medicines. However, a recent report states otherwise.
 
today.mims.com
 
20 Nov 2016 - General
 
The Access to Medicine Foundation has stated that ‘some drug makers are making headway’ as pharmaceutical industry has always been blamed for providing medications at higher prices that are hardly approachable for low and middle-income countries. According to AMF, pharmaceutical companies have started a partnership with each other to provide medications at reasonable cost. GSK has led the list of 20 top pharmaceutical companies for the fifth time due to its R and D, quality manufacturing, safety...
 (Total 108 words)